The efficacy and safety of 0.5% Levofloxacin versus fortified Cefazolin and Amikacin ophthalmic solution for the treatment of suspected and culture-proven cases of infectious bacterial keratitis: a comparative study

1. Boonpasart S, Kasetsuwan N, Puangsricharern V, Pariyakanok L, Jittpoonkusol T. Infectious keratitis at King Chulalongkorn Memorial Hospital: a 12-year retrospective study of 391 cases. J Med Assoc Thai. 2002; 85:217S-30S.Search in Google Scholar

2. American Academy of Ophthalmology Vision Rehabilitation Panel. Preferred Practice Pattern® Guidelines. Bacterial Keratitis. San Francisco: American Academy of Ophthalmology; 2008. Available at: http://www.aao.org/ppp.Search in Google Scholar

3. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 1991; 112:34S-47S.Search in Google Scholar

4. O’Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol. 1995; 113:1257-65.10.1001/archopht.1995.01100100045026Open DOISearch in Google Scholar

5. Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a doublemasked, randomized, controlled trial with conventional dual therapy. Ophthalmology. 1997; 104:1902-9.10.1016/S0161-6420(97)30009-8Search in Google Scholar

6. Blondeau JM. Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol. 2004; 49:73S-8S.10.1016/j.survophthal.2004.01.005Search in Google Scholar

7. Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison. Indian J Ophthalmol. 2007; 55:15-9.10.4103/0301-4738.29489Open DOISearch in Google Scholar

8. Jones DB. Decision making in the management of microbial keratitis. Ophthalmology. 1981; 88:814-20.10.1016/S0161-6420(81)34943-4Open DOISearch in Google Scholar

9. Panda A, Ahuja R, Sastry SS. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Eye. 1999; 13:744-7.10.1038/eye.1999.220Search in Google Scholar

10. Gangopadhyay N, Daniell M, Weih L, Taylor HR. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol. 2000; 84: 378-84.10.1136/bjo.84.4.378Open DOISearch in Google Scholar

11. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolones resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999; 106:1313-8.10.1016/S0161-6420(99)00716-2Search in Google Scholar

12. Daniell M. Overview: initial antimicrobial therapy for microbial keratitis. Br J Ophthalmol. 2003; 87:1172-4.10.1136/bjo.87.9.1172177182712928292Search in Google Scholar

13. Parmar P, Salman A, Kalavathy CM, Kaliamurthy J, Prasanth DA, Thomas PA, et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am J Ophthalmol. 2006; 141:282-6.10.1016/j.ajo.2005.08.08116458681Search in Google Scholar

14. Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology. 2007; 114:1622-9.10.1016/j.ophtha.2006.12.011Open DOISearch in Google Scholar

15. Holland EJ, McCarthy M, Holland S. The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery. Curr Med Res Opin. 2007; 23: 2955-60.10.1185/030079907X242728Search in Google Scholar

16. Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003; 136:500-5.10.1016/S0002-9394(03)00294-0Search in Google Scholar

17. Yamada M, Mochizuki H, Yamada K, Kawai M, Mashima Y. Aqueous humor levels of topically applied levofloxacin in human eyes. Curr Eye Res. 2002; 24: 403-6.10.1076/ceyr.24.5.403.8517Open DOISearch in Google Scholar

18. Colin J, Simonpoli S, Geldsetzer K, Ropo A. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol Scand. 2003; 81:611-3.10.1111/j.1395-3907.2003.00173.xOpen DOISearch in Google Scholar

19. Bucci FA Jr. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am J Ophthalmol. 2004; 137: 308-12.10.1016/j.ajo.2003.08.057Search in Google Scholar

20. Healy DP, Holland EJ, Nordlund ML, Dunn S, Chow C, Lindstrom RL, et al. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea. 2004; 23:255-63.10.1097/00003226-200404000-00007Open DOISearch in Google Scholar

21. Mallari PL, McCarty DJ, Daniell M, Taylor H. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol. 2001; 131:131-3.10.1016/S0002-9394(00)00642-5Open DOISearch in Google Scholar

22. Tanhehco TY, Chiavetta SV 3rd, Lee PP, Fowler AM, Afshari NA. “Cracked-mud” ciprofloxacin precipitates on a corneal graft. Ophthalmic Surg Lasers Imaging. 2005; 36:252-3.10.3928/1542-8877-20050501-14Search in Google Scholar

23. Awwad ST, Haddad W, Wang MX, Parmar D, Conger D, Cavanagh HD. Corneal intrastromal gatifloxacin crystal deposits after penetrating keratoplasty. Eye Contact Lens. 2004; 30:169-72.10.1097/01.ICL.0000133241.56713.2F15499240Open DOISearch in Google Scholar

24. Erjongmanee S, Kasetsuwan N, Phusitphoykai N, Puangsricharern V, Pariyakanok L. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis. J Med Assoc Thai. 2004; 87:83S-90S. Search in Google Scholar